TY - JOUR
T1 - Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization
AU - Kohl, Katrin S.
AU - Magnus, Manya
AU - Ball, Robert
AU - Halsey, Neal
AU - Shadomy, Sean
AU - Farley, Thomas A.
N1 - Funding Information:
Support: The study was funded in part through the Unmet Needs Awards by the National Vaccine Program Office ( http://www.dhhs.gov/nvpo/research/awards_2003.htm ).
PY - 2008/11/25
Y1 - 2008/11/25
N2 - We evaluated the applicability, reliability, sensitivity, and specificity of six standardized case definitions for adverse events following immunization (AEFI) (for fever, generalized convulsive seizure, hypotonic-hyporesponsive episode, intussusception, nodule, and persistent crying) developed by the Brighton Collaboration using the U.S. Vaccine Adverse Event Reporting System (VAERS). The evaluation included: (a) the development of codified search strings using standardized coding terminology, and (b) for sensitivity and specificity analyses, the development of a "gold standard" for case determination by clinical expert reviews, and its comparison against the application of the definitions to VAERS reports by nonclinicians. Application of the case definitions in an automated approach proved to be valid, feasible, and unlikely to miss confirmed cases of the reported clinical event. The definitions had variable but generally high sensitivity and specificity compared to clinician review, which in itself yielded inconsistent case determination. The study demonstrated the need for the developed standardized definitions for AEFI and their usefulness in passive surveillance.
AB - We evaluated the applicability, reliability, sensitivity, and specificity of six standardized case definitions for adverse events following immunization (AEFI) (for fever, generalized convulsive seizure, hypotonic-hyporesponsive episode, intussusception, nodule, and persistent crying) developed by the Brighton Collaboration using the U.S. Vaccine Adverse Event Reporting System (VAERS). The evaluation included: (a) the development of codified search strings using standardized coding terminology, and (b) for sensitivity and specificity analyses, the development of a "gold standard" for case determination by clinical expert reviews, and its comparison against the application of the definitions to VAERS reports by nonclinicians. Application of the case definitions in an automated approach proved to be valid, feasible, and unlikely to miss confirmed cases of the reported clinical event. The definitions had variable but generally high sensitivity and specificity compared to clinician review, which in itself yielded inconsistent case determination. The study demonstrated the need for the developed standardized definitions for AEFI and their usefulness in passive surveillance.
KW - Adverse events following immunization
KW - Case definitions
KW - Evaluation methodology
KW - Fever
KW - Generalized convulsive seizure
KW - Hypotonic-hyporesponsive episode
KW - Intussusception
KW - Nodule at injection site
KW - Persistent crying
UR - http://www.scopus.com/inward/record.url?scp=55749103875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55749103875&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2008.09.002
DO - 10.1016/j.vaccine.2008.09.002
M3 - Article
C2 - 18805456
AN - SCOPUS:55749103875
SN - 0264-410X
VL - 26
SP - 6349
EP - 6360
JO - Vaccine
JF - Vaccine
IS - 50
ER -